Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Vascular Grafts Market: By Product, By Source, By Application, By End User and Region Forecast 2019-2030
Vascular Grafts Market size was valued at US$ 2.29 billion in 2023 and expected to reach US$ 3.42 billion by 2030, at a significant CAGR of 8.4% from 2024-2030. A vascular graft is a tube-shaped synthetic material which is surgically implanted into the arteries or veins. These vascular grafts are used for vascular bypass operations or to create the vein access in hemodialysis patients. The size of the tube depends upon the size of the vein or artery replaced. Global market is primarily driven by the increase in the prevalence of vascular diseases due to lifestyle changes and food habit changes among the populace.
In addition, prevalence of the end-stage renal diseases, hypertension, and cardiac arrhythmias is expected to boost the market share furthermore. Moreover, increase in alcohol consumption, and tobacco intake are leading to chronic diseases and are expected to increase the demand for vascular grafts over the forecast period. However, the low reimbursement rates and high cost of the procedures are projected to hamper the growth of the market over the coming years.
Study Period
2024-2030Base Year
2023CAGR
8.4%Largest Market
Asia-PacificFastest Growing Market
North America
Global vascular grafts market is expected to have significant growth rate owing to the increase in R&D in development of the new vascular grafts and expansion of applications. For instance, Medtronic has developed stent graft system Endurant II AAA to treat abdominal aortic aneurysm. Furthermore, market is very dynamic due to the presence of big and small regional market players. Companies are adopting the strategies such as mergers and acquisitions to expand the market share.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2.29 billion |
Market Size in 2030 |
US$ 3.42 billion |
Market CAGR |
8.4% |
By Product Type |
|
By Source |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The vascular grafts market size was valued at US$ 2.29 billion in 2023 and set to reach US$ 3.42 billion by 2030, at a robust CAGR of 8.4% from 2024-2030.
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The market key players Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (Netherlands), Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), Axel Bio Corporation (U.S.)
1.Executive Summary |
2.Global Vascular Grafts Market Introduction |
2.1.Global Vascular Grafts Market - Taxonomy |
2.2.Global Vascular Grafts Market - Definitions |
2.2.1.Product Type |
2.2.2.Source |
2.2.3.Application |
2.2.4.End User |
2.2.5.Region |
3.Global Vascular Grafts Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Vascular Grafts Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Vascular Grafts Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Bypass Graft |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Endovascular Stent Graft |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Peripheral Vascular Graft |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Vascular Grafts Market By Source, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Synthetic |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biological |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Vascular Grafts Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Vascular Occlusion |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Renal Failure |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Coronary Artery Disease |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Vascular Grafts Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Ambulatory Surgical Centers |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Others |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Vascular Grafts Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Bypass Graft |
10.1.2.Endovascular Stent Graft |
10.1.3.Peripheral Vascular Graft |
10.1.4.Others |
10.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Synthetic |
10.2.2.Biological |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Vascular Occlusion |
10.3.2.Renal Failure |
10.3.3.Coronary Artery Disease |
10.3.4.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Ambulatory Surgical Centers |
10.4.3.Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Bypass Graft |
11.1.2.Endovascular Stent Graft |
11.1.3.Peripheral Vascular Graft |
11.1.4.Others |
11.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Synthetic |
11.2.2.Biological |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Vascular Occlusion |
11.3.2.Renal Failure |
11.3.3.Coronary Artery Disease |
11.3.4.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Ambulatory Surgical Centers |
11.4.3.Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Bypass Graft |
12.1.2.Endovascular Stent Graft |
12.1.3.Peripheral Vascular Graft |
12.1.4.Others |
12.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Synthetic |
12.2.2.Biological |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Vascular Occlusion |
12.3.2.Renal Failure |
12.3.3.Coronary Artery Disease |
12.3.4.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Ambulatory Surgical Centers |
12.4.3.Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Bypass Graft |
13.1.2.Endovascular Stent Graft |
13.1.3.Peripheral Vascular Graft |
13.1.4.Others |
13.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Synthetic |
13.2.2.Biological |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Vascular Occlusion |
13.3.2.Renal Failure |
13.3.3.Coronary Artery Disease |
13.3.4.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Ambulatory Surgical Centers |
13.4.3.Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Bypass Graft |
14.1.2.Endovascular Stent Graft |
14.1.3.Peripheral Vascular Graft |
14.1.4.Others |
14.2. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Synthetic |
14.2.2.Biological |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Vascular Occlusion |
14.3.2.Renal Failure |
14.3.3.Coronary Artery Disease |
14.3.4.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Ambulatory Surgical Centers |
14.4.3.Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Becton, Dickinson & Company (U.S) |
15.2.2.Medtronic (U.S) |
15.2.3.Revolutions Medical Corporation (U.S) |
15.2.4.Retractable Technologies, Inc. (U.S) |
15.2.5.Royal Imtech N.V. (Smiths Medical) (Netherlands |
15.2.6.Terumo Corporation (Japan) |
15.2.7.Unilife Corporation (U.S) |
15.2.8.Sol-Millennium Medical Group (China) |
15.2.9.Ultimed, Inc. (U.S) |
15.2.10.Axel Bio Corporation (U.S) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players